STRS Ohio’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

STRS Ohio’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,190	Closed	-$527K	–	1937
2017 Q4	$527K	Hold	4,190	–	–	﹤0.01%	1308
2017 Q3	$573K	Buy	4,190 +140	+3%	+$18.7K	﹤0.01%	1318
2017 Q2	$577K	Buy	+4,050	New	+$626K	﹤0.01%	1287
2013 Q3	–	Sell	-270	Closed	-$47.2K	–	1944
2013 Q2	$38K	Buy	+270	New	+$42.8K	﹤0.01%	1766

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

STRS Ohio's TTPH Position: Q1 2018 in Review

STRS Ohio sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2018, closing a stake of 4,190 shares — an estimated $527K sold.

STRS Ohio first reported a position in TTPH in Q2 2013 and held it in 4 quarters. The position peaked at $577K in Q2 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q1 2018.

STRS Ohio reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
STRS Ohio sold 4,190 Tetraphase Pharmaceuticals, Inc. shares in Q1 2018, an estimated $527K.
STRS Ohio first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
STRS Ohio's Tetraphase Pharmaceuticals, Inc. position peaked at $577K in Q2 2017.
94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2018.

Based on STRS Ohio's 13F filing for Q1 2018, filed 20 Apr 2018.